Abstract:TNF-receptor-associated factors (TRAFs) are intracellular proteins that bind to the cytoplasmic portion of TNF receptors and mediate downstream signaling. The six known TRAF proteins play overlapping yet distinct roles in controlling immune responses as well as cellular processes such as activation of NF-κB and JNK signaling pathways. For example, CD40 binds to TRAF2, TRAF3 and TRAF6 to control B cell differentiation, proliferation and growth.1 In contrast, binding of lymphotoxin-β receptor (LTβR) to TRAF2 and TRAF5 propagates signals leading to activation of NF-κB,2 while binding to TRAF3 induces negative regulation of this pathway and leads to apoptosis in tumor cells.3,4 Binding recognition is mediated by specific contacts of a consensus recognition sequence in the partner with residues in a hydrophobic crevice on the TRAF molecule. Since each of these protein-protein interactions occurs within this same binding crevice, it appears that TRAF-mediated cellular mechanisms may be regulated, in part, by the level of expression or recruitment of the adaptor proteins or receptors that are competing for the crevice.The specific contacts of CD40, LTβR and BAFF-R have been defined in crystal structures of the complex with TRAF3.5–7 In addition, the downstream regulator TANK and the viral oncogenic protein LMP1 from the Epstein Barr virus also bind to the same TRAF crevice and these contacts have also been described crystallographically.8,9 Comparison of these five crystal structures has revealed that the recognition motifs in each of these proteins are accommodated in one TRAF3 binding crevice and that the binding interface is structurally and functionally adaptive.10 In this chapter, the molecular details of the interactions will be described and correlated with the functional implications for multiple TRAF3 roles in cellular regulation.

A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation

Trimeric Coiled-Coil Domain of Human Pulmonary Surfactant Protein D Enhances Zinc-Binding Ability and Biologic Activity of Soluble TRAIL.

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative

A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor

TRAF Proteins in CD40 Signaling

Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor

C-terminus of TRAP in Staphylococcus Can Enhance the Activity of Lysozyme and Lysostaphin

Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers

Protein-Protein Interactions in TRAF3

TTRAP is a novel PML nuclear bodies-associated protein.

Insights into Ligand-Mediated Activation of an Oligomeric Ring-Shaped Gene-Regulatory Protein from Solution- and Solid-State NMR

TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells

The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors

TRAF proteins in CD154-induced NF-κB activation

Molecular Cloning of SLP-76, a 76-Kda Tyrosine Phosphoprotein Associated with Grb2 in T Cells

TRPA1 Covalent Ligand JT010 Modifies T Lymphocyte Activation

Death Decoy Receptor TR6/DcR3 Inhibits T Cell Chemotaxis in Vitro and in Vivo1

Engineering and therapeutic application of single-chain bivalent TGF-β family traps

Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo.

Time-resolved assessment of single-cell protein secretion by sequencing

Membrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biology